Skip to content

Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning

Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05762029
Enrollment
60
Registered
2023-03-09
Start date
2022-11-26
Completion date
2025-11-26
Last updated
2023-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Membrane Oxygenation, Poison;Medicinal

Keywords

Severe poisoning, Extracorporeal Membrane Oxygenation, Emergency medical care

Brief summary

This is a prospective, multicentre clinical study to determine the value of the Extracorporeal Membrane Oxygenation in the treatment of critically ill poisoning patients and whether there are significant differences in the prognosis of different types or doses of poison/drug poisoning. These conclusions may guide us on how to correctly perform Extracorporeal Membrane Oxygenation, including whether or when should this treatment enabled, the mode of Extracorporeal Membrane Oxygenation, whether to combine blood purification, treatment schedule and disembarkation time.

Detailed description

This study will be conducted in the Affiliated Hospital of Nantong University, the Sixth People's Hospital of Nantong University, the Branch of Affiliated Hospital of Nantong University, the People's Hospital of Qidong City, the People's Hospital of Rudong County, the People's Hospital of Rugao City, and the People's Hospital of Hai 'an City. It is expected that 60 patients with poisoning will be included, and the blood and urine samples of 60 patients will be collected and stored in the clinical trial sample database to evaluate and record the relevant indicators of the subjects. The relevant medical records in clinical treatment were analyzed and studied. Each subject will be numbered and a separate medical record will be established. The purpose of this prospective multicenter observational clinical study was to 1) investigate the value of Extracorporeal Membrane Oxygenation in the treatment of fatal poisoning; 2) To investigate the changes of patients' organ functions (heart, lung, liver, kidney, brain) during the Extracorporeal Membrane Oxygenation operation and the influence on the removal of toxins. In order to obtain a more powerful clinical basis to guide the rational use of the Extracorporeal Membrane Oxygenation technology in patients with fatal poisoning.

Interventions

None listed

Sponsors

Affiliated Hospital of Nantong University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Severe intoxication resulting in cardiac arrest, refractory malignant arrhythmia, refractory shock, refractory heart failure, respiratory failure. * Denying other available methods. * Indications for the use of the Extracorporeal membrane oxygenation exist.

Exclusion criteria

* Severely impaired state of consciousness prior to cardiac arrest; * Multiple organ dysfunction; * Uncontrolled traumatic bleeding, massive gastrointestinal bleeding, and active intracranial hemorrhage; * Left ventricular thrombosis; Severe aortic insufficiency.

Design outcomes

Primary

MeasureTime frameDescription
Death ratethrough study completion, assessed up to 3 yearDeath rate is used to assess the treatment capacity of Extracorporeal membrane oxygenation.
ComplicationFrom date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 10 daysComplication is used to assess the side effects of Extracorporeal membrane oxygenation.
Partial pressure of oxygenrandom time before performing extracorporeal membrane oxygenationPO₂ is used to indicate the state of internal respiration.
Oxygen saturationBefore perform the extracorporeal membrane oxygenationSO₂ is used to indicate the state of internal respiration.

Countries

China

Contacts

Primary ContactZhongwei Huang, Master
HZW889@163.com15335051939

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026